Introduction to possible side effects of Cresflut

Crinecerfont,is a corticotropin-releasing factor1 receptor antagonist, and Crinecerfont can also be used as glucocorticoid replacement therapy Adjuvant therapy, whichaims to act precisely on relevant targets and reduce androgen levels more specifically, thereby potentially reducing the dose of steroids, provides a groundbreaking treatment option for patients with classic congenital adrenal hyperplasia (CAH).

Crisflutide is indicated for use in adults and children 4 years of age and older with classic CAH. The recommended dose for adults is 100 mg taken orally twice daily, morning and evening with food. The dosage for pediatric patients is based on body weight: Children above 10kg20kg and below, 25mg twice daily; 20kgand above< /span>Children under 55kg should take 50mg twice a day; children weighing 55kg or more should take 100mg twice a day.

While crisflutide brings new treatment hope toCAH patients, it may come with some side effects. The most common adverse reactions in adult patients include fatigue, headache, dizziness, arthralgia, back pain, decreased appetite, and myalgia. These symptoms are mostly mild to moderate and may gradually lessen with treatment.

For pediatric patients, the most common adverse reactions are headache, abdominal pain, fatigue, nasal congestion, and epistaxis. Parents should pay close attention to their children's reactions and communicate with the doctor promptly if there are any abnormalities or symptoms worsen.

In addition, crisflutide may cause allergic reactions, including throat tightness, angioedema, and generalized rash. If these clinically significant allergic reactions occur, the drug should be discontinued immediately and appropriate treatment should be received.

Of note, corticosteroids should be continued during crisflutide treatment to avoid the risk of acute adrenal insufficiency or adrenal crisis. Corticosteroid dose adjustments must be made under the supervision of a medical professional and should not be lower than the dose required for cortisol replacement. Glucocorticoid stress doses should be used in situations of increased cortisol demand, such as acute intercurrent illness, severe trauma, or surgery.

In short, Cresflut provides a new treatment option for CAH patients, but patients should pay close attention to possible side effects during medication and reasonably adjust the treatment plan under the guidance of a doctor.

Reference link: https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218808s000,218820s000lbl.pdf